AKT3 and breast carcinoma: Furthermore, AKT3 is a subtype of AKT.[32] Divergent functions of AKT3 have been observed in breast cancer (BRCA) and lung adenocarcinoma (LUAD).[33] Our findings demonstrated that AKT3 is highly expressed and promotes the progression of HNSC.